Literature DB >> 170489

Lipids of cultured hepatoma cells: VII. Structural analyses of glycerolipids in minimal deviation hepatoma 7288C.

R D Wiegand, R Wood.   

Abstract

Phosphatidylcholine. phosphatidylethanolamine, and triglycerides were isolated from minimal deviation hepatoma 7288C cells cultured as monolayers to confluency in roller flasks containing Swim's 77 medium supplemented with 5% fetal calf serum, plus 20%, 10%, or 5% bovine serum. Fatty acid distribution at each position of glycerol was determined for the 3 glycerolipid classes, and carbon number distributions of triglycerides and diglycerides derived from phosphatidylcholine and phosphatidylethanolamine were quantitated by high temperature gas liquid chromatography. Fatty acid composition was only marginally affected by the level of bovine serum in the culture medium. Percentage composition of fatty acids esterified at each position of the 3 glycerolipids was different, indicating a nonrandom distribution of acyl groups in triglycerides and the 2 diacyl phosphatides. The carbon number distribution of diglycerides derived from phosphatidylcholine and phosphatidylethanolamine was different, and neither carbon number distribution agreed with the calculated 1-random, 2-random diacyl distribution, thus indicating pairing of certain acids in the diglycerides derived from these phospholipd classes. The determined triglyceride carbon number distributions did not show complete agreement with those calculated, assuming a 1-random, 2-random, 3-random type of fatty acyl distribution, suggesting preferential pairing of some acids in this lipid class. The 1-, 2-diglycerides derived from phosphatidylcholine, phosphatidylethanolamine, and triglycerides differed, indicating either selectivity in utilization of diglyceride species in biosynthesis of these glycerolipids, or modification of glycerolipids after their initial synthesis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170489     DOI: 10.1007/bf02532359

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  16 in total

1.  Sterospecific analysis of hepatoma, host liver, and normal rat liver triglycerides from animals on chow and fat free diets.

Authors:  R Wood
Journal:  Lipids       Date:  1975-07       Impact factor: 1.880

2.  In vitro desaturation of 1-14C linoleic acid in Novikoff hepatoma.

Authors:  L Chiappe; O Mercuri; M E Detomás
Journal:  Lipids       Date:  1974-05       Impact factor: 1.880

3.  Tumor lipids: structural analyses of the phospholipids.

Authors:  R Wood; R D Harlow
Journal:  Arch Biochem Biophys       Date:  1970-11       Impact factor: 4.013

4.  Composition of rat liver triacylglycerols and diacylglycerols.

Authors:  B Akesson
Journal:  Eur J Biochem       Date:  1969-07

5.  Tumor lipids: metabolic relationships derived from structural analyses of acyl, alkyl, and alk-l-enyl moieties of neutral glycerides and phosphoglycerides.

Authors:  R Wood; F Snyder
Journal:  Arch Biochem Biophys       Date:  1969-05       Impact factor: 4.013

6.  Lipids of cultured hepatoma cells. II. Effect of media lipids on cellular phospholipids.

Authors:  R Wood; J Falch
Journal:  Lipids       Date:  1973-12       Impact factor: 1.880

7.  Lipids of cultured hepatoma cells. I. Effect of serum lipid levels on cell and media lipids.

Authors:  R Wood
Journal:  Lipids       Date:  1973-12       Impact factor: 1.880

8.  Lipids of cultured hepatoma cells: V. Distribution of isomeric monoene fatty acids in individual lipid classes.

Authors:  R Wood; J Falch; R D Wiegand
Journal:  Lipids       Date:  1974-12       Impact factor: 1.880

9.  Stereospecific analysis of triglycerides: an alternative method.

Authors:  H Brockerhoff
Journal:  J Lipid Res       Date:  1967-05       Impact factor: 5.922

10.  Metabolism of glycerolipids. III. Reactivity of various acyl esters of coenzyme A with alpha'-acylglycerophosphorylcholine, and positional specificities in lecithin synthesis.

Authors:  W E LANDS; I MERKL
Journal:  J Biol Chem       Date:  1963-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.